Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-07
2009-02-17
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S269000, C514S258100, C514S266310, C544S284000, C544S289000, C544S298000, C544S253000
Reexamination Certificate
active
07491728
ABSTRACT:
The pyrimidinone compounds are disclosed. Methods of preparing the pyrimidinone compounds are also disclosed.
REFERENCES:
patent: 3185689 (1965-05-01), Ruschg et al.
patent: 5300477 (1994-04-01), Tice
patent: 5726124 (1998-03-01), Tice et al.
patent: 5948775 (1999-09-01), Koko et al.
patent: WO 2004/092121 (2004-10-01), None
Nemeth, J. Molec. Endocrin., 2002, 29, 15-21.
Fox, Current Opinion in Pharm, 2002, 2: 338-344.
Nemeth, Cell Calcium, 35 (2004) 283-289.
Stewart, N. Eng. J. Med. 351: 4, Jul. 2004, 324-326.
Cunningham, J. Am. Soc. Nephrol. 18: 223-234, 2007.
Stajer, et al., Magyar Kemiai Folyoirat (1986), 92(5), 234-6 (Abstract).
Fulop, et al., Synthesis (1985), (12), 1148-9.
Schubert, et al., Journal fuer Praktische Chemie (Leipzig) (1970), 312(3), 494-506.
Sprio, et al., Ann. di Chim. (Rome, IT) (1970), 60(5), 393-6.
Kato, et al., Yakugaku Zasshi (1970), 90(4), 509-11.
Mitter, et al., Quart. J. Indian Chem. Soc. (1927), 4, 149-57.
Mitter, et al., Quart. J. Indian Chem. Soc. (1925), 2, 61-70.
Mitter, et al., Journal of the Chemical Society, Transactions (1923), 123, 2179-84.
Arai, et al., Heterocycles (2001), 55(12), 2283-2287.
Tice, et al., Tetrahedron (2001), 57(14), 2689-2700.
Jayakumar, et al., Tetrahedron Letters (2001), 42(11), 2235-2237.
Rossi, et al., Tetrahedron (1999), 55(22), 6921-6970.
Mukherjee, et al., Heterocycles (1998), 47(2), 933-950.
Rossi, et al., Tetrahedron (1997), 53(41), 14107-14114.
Holzer, et al., Liebigs Annalen der Chemie (1994), (9), 901-9.
Mazumdar, et al., Tetrahedron (1994), 50(25), 7579-88.
Gupta, et al., India Patent 158084, issued Aug. 30, 1986.
Jeong, An Efficient Synthesis of 3-Substituted 3H-Pyrimidin-4ones, Organic Letters, vol. 6, No. 6, 2004 (pp. 1013-1016).
Juby, Peter F., et al: “Antiallergy agents. 2. 2-Phenyl-5-(1H-tetrazol-5-yl) pyrimidin-4(3H)-ones” Journal of Medicinal Chemistry (1982) 25(10), 1145-50.
Database Caplus [Online], Chemical Abstracts Service, Columbus, Ohio, US; Krivopalov, V.P. et al: ynthesis of 2- and 4-chloroprimides bearing hydroxyphenyl substituents by reaction of Vilsmeier-Haack reagents with (hydroxyphenyl)pyrimidin-2- and -4-ones XP002484028 1993.
Database Caplus [Online], Chemical Abstracts Service, Columbus Ohio, US; Krivopalov, V.P., et al: “Method of preparing chloro azines containing an o-hydroxyphenyl group” XP002484029 1995.
Database Caplus [Online] Chemical Abstracts Service, Columbus, Ohio, US; Miyazaki, Hiroshi, et al: “2-Substituted-4-methyl-6-pyrimidone” XP002484027 1973.
Balanddrin Manuel F.
Fox John
Geoffroy Otto
Huang Guangfei
Luengo Juan
Berch Mark L
Jaisle Cecilia M
Kinzig Charles M.
McCarthy Mary E.
SmithKline Beecham Corp.
LandOfFree
Pyrimidinone compounds as calcilytics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidinone compounds as calcilytics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidinone compounds as calcilytics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4097741